Navigation Links
SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board
Date:8/6/2008

Leading Non-Fusion Spine Surgeon Supports Company's Goals for Global

Medical Research, Education

SAN DIEGO, Aug. 6 /PRNewswire/ -- SpineMark Corporation, a spine care services organization that partners with hospitals and physicians to develop spine centers, research organizations and medical education training centers, has appointed Dr. Rudolf Bertagnoli, chairman and founder of ProSpine (Bogen, Germany), as chairman of its International Medical Advisory Board. In this role, Bertagnoli will oversee the recruitment of a global panel of physician advisors to manage the development of spine centers of excellence and clinical trials being conducted outside the United States to evaluate new technologies and treatment options for spinal disorders and injuries.

"Dr. Bertagnoli is an active leader in global spinal research studies with more than 20 years of experience pioneering fusion and non-fusion technologies for treatment of spinal disorders," said Marcy T. Rogers, M.Ed., president and CEO of SpineMark. "We believe in bringing together the best spine physicians from around the world to help us build international bridges for education, facility development and clinical research. Dr. Bertagnoli's experience is a great fit to help us achieve our goals of providing advanced spine treatment options to patients on a global level."

Bertagnoli is the founder, CMO and CEO of ProSpine, the first European Centre for Spine Arthroplasty and Associated Non-Fusion Technologies, which has five facilities across Germany. Bertagnoli has been published in key medical journals worldwide, and has trained over 3,000 surgeons from 50 countries in new minimally invasive spine techniques. Additionally, he is the founder and former president of the Spine Arthroplasty Society (SAS), president of Spine Evolution Nucleus Europe (SEN), a member of the North American Spine Society (NASS), a faculty member of IMAST and a past German representative of the International Society for Minimal Intervention in Spinal Surgery (ISMISS).

"SpineMark's concept of integrating clinical research into a global network of centers of excellence resembles the vision I have for my facilities in Germany," said Bertagnoli. "We share a dedication to ensuring that patients can receive quality care. I look forward to contributing to the creation of a global spinal research network through SpineMark's international partnerships."

Bertagnoli graduated in 1984 from the University of Vienna, Austria, and worked at emergency hospitals in Vienna and Linz before moving to the German Center of Spine Surgery in Bad Wildungen, Germany, in 1986. From 1989 to 1994, Bertagnoli held a position as senior physician and head of the spine department at the Orthopedic University Hospital, Georg-August-University Goettingen, Germany. He went on to lead spine units in several German cities before founding ProSpine in 2005.

About SpineMark

SpineMark Corporation is an innovative service organization dedicated to transforming the delivery of spine care. The company partners with hospitals and physicians across the United States and abroad to develop and operate comprehensive, evidence-based spine centers of excellence. By building a global network of spine centers, spine research organizations and state-of-the-art medical conference facilities, SpineMark is improving the overall quality of life of patients afflicted with spine disorders and injuries.

Driven by the specialized experience and expertise of its leadership team and medical advisory board, SpineMark's goal is to create a global network, based on clinically validated best practices for spine care that streamline diagnosis and treatment, simplify referrals and accelerate the recovery process.


'/>"/>
SOURCE SpineMark Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
2. SAFC Appoints New Vice President of Quality and Regulatory Affairs
3. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
4. ARCA biopharma Appoints James Carr as Vice President of Marketing
5. China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
6. Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales
7. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
8. Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
9. Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
10. AMT Appoints Director Global Marketing and Sales
11. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... in the World Technology Awards. uBiome is one of just six company finalists ... categories. , In addition to uBiome, companies nominated as finalists in this year’s ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
(Date:12/8/2016)... SEOUL, South Korea , Dec. 8, 2016 /PRNewswire/ ... completed a $21 billion KRW (US $18.9M) Series A ... Management, Kolon Investment, G.N. Tech Venture and SNU Bio ... by Eutilex to 30.5 billion KRW (US $27.7M) since ... will help Eutilex to bolster the development and commercialization ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... Nov. 14, 2016  xG Technology, Inc. ("xG" or ... critical wireless communications for use in challenging operating environments, ... 30, 2016. Management will hold a conference call to ... p.m. Eastern Time (details below). Key Recent ... $16 million binding agreement to acquire Vislink Communication Systems. ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... offering. The report forecasts the ... at a CAGR of 12.28% during the period 2016-2020. ... analysis with inputs from industry experts. The report covers the market ... also includes a discussion of the key vendors operating in this ...
Breaking Biology News(10 mins):